Eco Animal Health Group Plc logo

Eco Animal Health Group Plc(LSE) EAH

Market Cap£64.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)+443%
5 Year-66%
1 Year+15%
1 Month-1%
£0.95
+0.00%
+0.00Today
Eco Animal Health Group Plc last closing stock price
MetricPriceDate
Last closeGBX 95.502026-10-23
Eco Animal Health Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.6%GBX 94.002026-10-16
1 month-0.52%GBX 96.002026-09-23
3 month-5.45%GBX 101.002026-07-24
Year to date-8.61%GBX 104.502025-12-31
1 year+15.06%GBX 83.002025-10-23
3 year-14.73%GBX 112.002023-10-24
5 year-66.49%GBX 285.002021-10-22
Since inception+443.04%GBX 0.181992-12-24

Eco Animal Health Group Plc Financials at a Glance

Market Cap

£64.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£167.12M

Net Income (TTM)

£3.88M

EPS (TTM)

£0.03

P/E Ratio

29.57

Dividend

£0.00

Beta (Volatility)

-0.07 (Low)

Price

£0.95

Volume

55,401

Open

£0.97

Previous Close

£0.95

Daily Range

£0.95 - £0.97

52-Week Range

£0.80 - £1.17

Estimated Earnings Date

Nov 19, 2026

EAH News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eco Animal Health Group Plc

ECO Animal Health Group plc, established in 1972 and headquartered in New Malden, United Kingdom, specializes in the research, regulatory approval, and distribution of veterinary pharmaceutical solutions. The company offers a range of products aimed at improving animal health, particularly in livestock and companion animals.

Products and Services
  • Aivlosin, a macrolide antibiotic for pigs and poultry
  • Generic drugs including Ecomectin and Ecoheart for parasitic infestations
  • Chlortetracycline and Oxytetracycline for bacterial infections in livestock
Growth Outlook
  • Recent quarterly revenue reached £48.1 million, indicating strong demand
  • Gross profit margin improved to 47.7% in the latest quarter
  • Positive cash flow from operations of £8.75 million supports future investments
Financial Highlights
  • Trailing twelve-month revenue of £181.5 million reflects consistent growth
  • Net income of £2.55 million reported in the latest quarter
  • Current ratio of 3.42 indicates strong liquidity position
ECO Animal Health Group plc operates in the specialized drug manufacturing sector, focusing on veterinary pharmaceuticals. The company has demonstrated resilience and growth potential, as evidenced by its recent financial performance. The latest quarterly revenue of £48.1 million showcases a robust demand for its products, particularly Aivlosin, which addresses critical health issues in livestock. The gross profit margin of 47.7% indicates effective cost management and pricing strategies. The company maintains a strong liquidity position with a current ratio of 3.42, allowing for flexibility in operations and potential expansion. Additionally, the positive cash flow from operations of £8.75 million provides a solid foundation for future investments in research and development, further enhancing its product offerings. Overall, ECO Animal Health Group plc presents a compelling opportunity for investors interested in the veterinary pharmaceutical sector, backed by a strong financial performance and a commitment to improving animal health globally.
AI Generated • Oct 4, 2026

Industry

Pharmaceuticals

Employees

213

CEO

David Charles Hallas

Headquarters

London, LO N14 6BN, GB

EAH Financials

Key Financial Metrics (TTM)

Gross Margin

48.55%

Operating Margin

6.37%

Net Income Margin

2.50%

Return on Equity

2.55%

Return on Capital

5.87%

Return on Assets

1.85%

Earnings Yield

3.38%

Dividend Yield

0.00%

Payout Ratio

1.14%

Stock Overview

Market Cap

£64.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

67.76M

Volume

55.40K

Avg. Volume

173.90K

Financials (TTM)

Gross Profit

£78.41M

Operating Income

£9.82M

EBITDA

£15.63M

Operating Cash Flow

£18.29M

Capital Expenditure

-£548.00K

Free Cash Flow

£17.74M

Cash & ST Invst.

£25.43M

Total Debt

£4.93M

Eco Animal Health Group Plc Performance Analysis

Eco Animal Health Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31GBP 85,311,0003.8%
20242024-03-31GBP 89,422,0004.8%
20252025-03-31GBP 79,596,000-11.0%
20262026-03-31GBP 87,525,00010.0%
Eco Animal Health Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-35.5%
Q42025-03-3139.9%
Q22025-09-30-15.1%
Q42026-03-3122.2%
Eco Animal Health Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31GBP 0.01N/A
20242024-03-31GBP 0.023.4%
20252025-03-31GBP 0.0259.9%
20262026-03-31GBP 0.0329.6%
Eco Animal Health Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-09-30-173.3%
Q42025-03-31297.2%
Q22025-09-30-111.0%
Q42026-03-31783.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

£48.13M

-6.4%

Gross Profit

£22.95M

+3.4%

Gross Margin

47.68%

N/A

Market Cap

£64.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£303.81K

N/A

Employees

213

N/A

Net Income

£2.55M

+8.4%

EBITDA

£5.82M

+0.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

£25.43M

+13.7%

Total Debt

£4.93M

+22.6%

Accounts Receivable

£25.55M

-14.4%

Inventory

£13.51M

-20.3%

Long Term Debt

£4.17M

+23.5%

Short Term Debt

£760.00K

+17.6%

Return on Assets

1.85%

N/A

Return on Invested Capital

5.59%

N/A

Free Cash Flow

£8.63M

+86.4%

Operating Cash Flow

£8.75M

+84.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KOO.LKooth plc
£1.83+0.00%
STX.LShield Therapeutics plc
£0.06-1.79%
CREO.LCreo Medical Limited
£0.11+0.00%
VLG.LVenture Life Group plc
£0.67-1.47%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$147.49+1.89%
TAT&T
$20.93-7.96%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%
NUNu Holdings
$15.16+2.92%

Questions About EAH

What is the current price of Eco Animal Health Group Plc?

Eco Animal Health Group Plc is trading at £0.95 per share.

What is the 52-week range for Eco Animal Health Group Plc?

Over the past 52 weeks, Eco Animal Health Group Plc has traded between £0.80 and £1.17.

How much debt does Eco Animal Health Group Plc have?

As of the most recent reporting period, Eco Animal Health Group Plc reported total debt of £4.93M.

How much cash does Eco Animal Health Group Plc have on hand?

Eco Animal Health Group Plc reported £25.43M in cash and cash equivalents in its most recent financial results.

What is Eco Animal Health Group Plc’s dividend yield?

Eco Animal Health Group Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.